ICYMI: A Push for Affordable Prices for Taxpayer-Funded Drugs

May 29, 2018 News, Press Releases

“We have an incredibly powerful, incredibly productive research and development program being run by N.I.H.,” Ameet Sarpatwari, an instructor at Harvard Medical School, said. “Taxpayers put in money that is paying big dividends, and yet we pay higher prices for prescription drugs than any other country. In effect, we have taxpayers paying twice.”

ALERT: PhRMA Spends Record $$$ Lobbying

April 20, 2018 News

WASHINGTON, DC — Patients For Affordable Drugs' Executive Director, Ben Wakana, issued the following statement regarding the news that PhRMA, the pharmaceutical industry’s main trade organization, broke a record for money spent lobbying in the first quarter of 2018.

“Drug corporations are running scared. The public knows the truth about America’s rigged prescription drug pricing system, so PhRMA is doing what PhRMA does best, lobbying lawmakers behind closed doors. Patients are demanding lower drug prices, and in response, PhRMA fattened its lobbying budget, revealing the industry’s true priorities.”

JOIN US

Patients For Affordable Drugs is the only independent national patient organization focused exclusively on achieving policy changes to lower the price of prescription drugs.